Purchase Order 36C26223P0372

Award Date 12/16/22
Potential Completion Date 12/15/23
Potential Value $216K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) awarded a $121,250 firm fixed price purchase order to Boston Scientific Corp for TheraSphere Y-90 cancer treatment, including the TheraSphere radioactive microspheres, administration kits, and administration sets. This order was placed through the VA's Greater Los Angeles Healthcare System to support radioembolization procedures for non-operable liver cancer patients. The purchase order has a one-year period of performance and does not include a...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a sole source purchase order contract to Boston Scientific Corp, doing business as Boston Scientific, to provide a 12-month supply of Therasphere Yttrium-90 (Y-90) radiopharmaceutical doses. The $143,960.00 firm fixed price contract will support the Dayton VA Medical Center's Nuclear Medicine Department in treating hepatocellular carcinoma. As the exclusive manufacturer of Therasphere, Boston Scientific was...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Boston Scientific Corp, a for-profit medical device manufacturer, to provide TheraSphere yttrium-90 glass microsphere radiotherapy treatments. The $230,050 contract has a completion date of September 30, 2022. No set-aside designation was used. The TheraSphere treatment involves infusing microscopic radioactive glass microspheres into the arteries feeding liver tumors to deliver high...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a $171,000 purchase order to Boston Scientific Corporation for the delivery of Y-90 Theraspheres. As the prime contractor, Boston Scientific will provide radioactive microspheres used in interventional radiology procedures to treat cancer in the liver. The single award firm fixed price contract has a base period of performance from September 2023 through February 2024 for the medical...
Boston Scientific Corporation, doing business as Boston Scientific, has been awarded a $89,730 firm fixed price purchase order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to provide TheraSphere Y-90 glass microspheres. The place of performance is in Marlborough, Massachusetts and the period of performance concludes on September 30, 2023. No set-aside designation was applied to this procurement. The TheraSphere Y-90 radioactive...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $71,980 firm-fixed-price purchase order to Boston Scientific Corp, a leading manufacturer of medical devices, for the provision of Yttrium 90 (Y90) TheraSphere microbeads. This contract has no set-aside designation and is scheduled for completion by September 30, 2023. The award is associated with a larger $3.5 million IDIQ contract the VA has with Boston Scientific to provide TheraSphere Y-90 radioactive...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded Boston Scientific Corporation a $228,000 firm fixed price delivery order for TheraSphere Y-90 radioactive microspheres. As the prime contractor, Boston Scientific will provide interventional radiology treatment services utilizing TheraSphere Y-90 microspheres for radioactive therapy. This delivery order was issued against the company's existing indefinite delivery contract with the VA...
This federal contract award is for the delivery of TheraSphere Y-90 radioactive microspheres to the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 22 (VISN 22). The $963,835.00 firm fixed price delivery order was awarded to Boston Scientific Corp, a leading manufacturer of medical devices, on December 18, 2024. The contract has a ceiling value of $963,835.00 and an ultimate completion date of December 17, 2025. This delivery order is associated with a...
Boston Scientific Corporation, doing business as Boston Scientific, was awarded a $313,200 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to provide Yttrium-90 TheraSphere radioactive microspheres. This delivery order was issued against the company's existing indefinite delivery contract with the VA worth up to $295 million over five years to supply surgical implants and related services. No set-aside...
The U.S. Department of Veterans Affairs (VA) has awarded a sole-source, firm-fixed-price contract to Boston Scientific Corp for the supply of Y-90 TheraSphere doses and associated administration materials. The contract, valued at $777,740.00, covers an initial 2-year base period from October 1, 2022, to September 30, 2024, with an option to extend for an additional year through September 30, 2024. This contract is not set-aside. The Y-90 TheraSphere doses are used for the treatment of liver...

The Department of Veterans Affairs awarded a $215,695 purchase order to Boston Scientific Corporation to provide TheraSphere Y-90 radioactive microspheres in unit dose form for treatment of hepatocellular carcinoma at the Phoenix VA Health Care System. This award was made non-competitively under the authority of FAR 6.302-1 as Boston Scientific was determined to be the only responsible source able to meet the agency's requirement for the ready-to-use radiopharmaceutical supplies as specified in a November 2022 special notice. No set aside designation was applied. The period of performance for delivering the TheraSphere injections is through December 2023. Additionally, Boston Scientific holds a $3.5 million indefinite delivery contract from 2015 through 2028 to provide these same supplies to the VA, with $1.3 million in delivery orders issued during the first year of that contract.

Generated 3/5/24, 9:03 PM